Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure

Bone

Volumn 33, Issue 3, 2003, Pages 372-379

  Frolik, Charles A ^a   Black, Elwood C ^a   Cain, Ricky L ^a   Satterwhite, Julie H ^a   Brown Augsburger, Patricia L ^a   Sato, Masahiko ^a   Hock, Janet M ^b  

^a ELI LILLY AND COMPANY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE[1-34]; PHOSPHATE; RECOMBINANT HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BIOCHEMISTRY; BIOSYNTHESIS; BONE MASS; BONE METABOLISM; CALCIUM BLOOD LEVEL; CATABOLISM; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG RESPONSE; HORMONE ACTION; HORMONE BLOOD LEVEL; MALE; NONHUMAN; OSTEOLYSIS; PHOSPHATE BLOOD LEVEL; PREDICTION; RAT; TIBIA;

EID: 0042333459     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(03)00202-3     Document Type: Article

References (41)

1. Abou-Samra A.B., Goldsmith P.K., Xie L.Y., Juppner H., Spiegel A.M., Segre G.V. Down-regulation of parathyroid (PTH)/PTH-related peptide receptor immunoreactivity and PTH binding in opossum kidney cells by PTH and dexamethasone. Endocrinology. 135:1994;2588-2594.
2. Bauer W., Aub J.C., Albright F. Studies of calcium and phosphorus metabolism a study of bone trabeculae as a readily available reserve supply of calcium . J Exp Med. 49:1929;145-162.
3. Burrows R.B. Variations produced in bones of growing rats by parathyroid extract. Am J Anat. 62:1938;237-290.
4. Chang S.L., Hofmann G.A., Zhang L., Deftos L.J., Banga A.K. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. J Control Release. 66:2000;127-133.
5. Codrons V., Vanderbist F., Verbeeck R.K., Arras M., Lison D., Preat V., Vanbever R. Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats. J Pharm Sci. 92:2003;938-950.
6. Cosman F., Shen V., Herrington B., Lindsay R. Response of the parathyroid gland to infusion of parathyroid hormone (1-34) demonstration of suppression of endogenous secretion using immunoradiometric intact PTH (1-84) assay . J Clin Endocrinol Metab. 73:1991;1345-1351.
7. Dempster D.W., Cosman F., Parisien M., Shen V., Lindsay R. Anabolic actions of parathyroid hormone on bone. Endocr Rev. 14:1993;690-709.
8. Dobnig H., Turner R.T. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats. Endocrinology. 138:1997;4607-4612.
9. Fox J., Miller M.A., Stroup G.B., Nemeth E.F., Miller S.C. Plasma levels of parathyroid hormone that induce anabolic effects in bone of ovariectomized rats can be achieved by stimulation of endogenous hormone secretion. Bone. 21:1997;163-169.
10. Gowen M., Stroup G.B., Dodds R.A., James I.E., Votta B.J., Smith B.R., Bhatnagar P.K., Lago A.M., Callahan J.F., DelMar E.G., Miller M.A., Nemeth E.F., Fox J. Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest. 105:2000;1595-1604.
11. Gunness-Hey M., Gera I., Fonseca J., Raisz L.G., Hock J.M. 1,25-Dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats. Calcif Tissue Int. 43:1988;284-288.
12. Gunness-Hey M., Hock J.M. Increased trabecular bone mass in rats treated with synthetic parathyroid hormone. Metab Bone Dis Rel Res. 5:1984;177-181.
13. 1 cells. Am J Physiol. 273:1997;E383-393.
14. Hefti E., Trechsel U., Bonjour J.P., Fleisch H., Schenk R. Increase of whole-body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone. Clin Sci. 62:1982;389-396.
15. Hock J. Anabolic actions of PTH in the skeleton of animals. J Musculoskel Neuron Interact. 2:2001;33-47.
16. Hock J.M., Fonseca J., Gunness-Hey M., Kemp B.E., Martin T. Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) and PTH 1-34 on bone in rats. Endocrinology. 125:1989;2022-2027.
17. Hock J.M., Gera I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res. 7:1992;65-72.
18. Hock J.M., Hummert J.R., Boyce R., Fonseca J., Raisz L.G. Resorption is not essential for the stimulation of bone growth by hPTH(1-34) in rats in vivo. J Bone Miner Res. 4:1989;449-458.
19. Hodsman A.B., Fraher L.J., Watson P.H., Ostbye T., Stitt L.W., Adachi J.D., Taves D.H., Drost D. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in posmenopausal women with osteoporosis. J Clin Endocrin Metab. 82:1997;620-628.
20. Kohno T., Murasugi N., Sakurai H., Watabe K., Nakamuta H., Koida M., Sugie Y., Nomura M., Yanagawa A. Development of a highly sensitive and specific two-site enzyme immunoassay for parathyroid hormone (1-34) application to pharmacokinetic study on intranasal parathyroid hormone (1-34) in human . J Clin Lab Anal. 12:1998;268-275.
21. Leone-Bay A., Sato M., Paton D., Hunt A.H., Sarubbi D., Carozza M., Chou J., McDonough J., Baughman R.A. Oral delivery of biologically active parathyroid hormone. Pharm Res. 18:2001;964-970.
22. Lindsay R., Nieves J., Henneman E., Shen V., Cosman F. Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1-34) kinetics and biochemical response in estrogenized osteoporotic patients . J Clin Endocrinol Metab. 77:1993;1535-1539.
23. Mitchell J., Goltzman D. Mechanisms of homologous and heterologous regulation of parathyroid hormone receptors in the rat osteosarcoma cell line UMR-106. Endocrinology. 126:1990;2650-2660.
24. Mitlak B.H., Williams D.C., Bryant H.U., Paul D.C., Neer R.M. Intermittent administration of bovine PTH(1-34) increases serum 1,25-dihydroxyvitamin D concentrations and spinal bone density in senile (23 month old) rats. J Bone Miner Res. 7:1992;479-484.
25. Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., Reginster J.-Y., Hodsman A.B., Eriksen E.F., Ish-Shalom S., Genant H.K., Wang O., Mitlak B.H. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. New Engl J Med. 344:2001;1434-1441.
26. Parsons J.A. Parathyroid physiology and the skeleton. Bourne G. Biochemistry and physiology of bone. IV. 1976;271-298 Academic Press, New York.
27. Parsons J.A., Neer R.M., Potts J.T. Jr. Initial fall of plasma calcium after intravenous injection of parathyroid hormone. Endocrinology. 89:1971;735-740.
28. Parsons J.A., Robinson C.J. Calcium shift into bone causing transient hypocalcemia after injection of parathyroid hormone. Nature. 230:1971;581-582.
29. Podbesek R., Eduoard C., Meunier P.J., Parsons J.A., Reeve J., Stevenson R.W., Zanelli J.M. Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology. 112:1983;1000-1006.
30. Podbesek R.D., Mawer E.B., Zanelli G.D., Parsons J.A., Reeve J. Intestinal absorption of calcium in greyhounds the response to intermittent and continuous administration of human synthetic parathyroid hormone fragment 1-34 (hPTH 1-34) . Clin Sci. 67:1984;591-599.
31. Pugsley L.I., Selye H. The histological changes in the bone responsible for the action of parathyroid hormone on the calcium metabolism of the rat. J Physiol (Lond). 79:1933;113-117.
32. Pun K.K., Ho P.W., Nissenson R.A., Arnaud C.D. Desensitization of parathyroid hormone receptors on cultured bone cells. J Bone Miner Res. 5:1990;1193-1200.
33. Reeve J., Arlot M., Bernat M., Charhon S., Eduoard C., Slovik D., Vismans F., Meunier P. Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis the influence of human parathyroid fragment (hPTH 1-34) therapy . Metab Bone Disease Rel Res. 3:1981;23-30.
34. Riond J.L., Fischer G.V.I., Kuffer B., Toromanoff A., Forrer R. Influence of the dosing frequency of parathyroid hormone (1-38) on its anabolic effect in bone and on the balance of calcium, phosphorus and magnesium. Z Ernahrungswissenschaft. 37:1998;183-189.
35. Sato M., Zeng G.Q., Turner C.H. 1997 Biosynthetic human PTH (1-34) effects on bone quality in aged ovariectomized rats. Endocrinology. 138:1997;4330-4337.
36. Simmons H.A., Pirie C.M., Thompson D.D., Ke H.Z. Parathyroid hormone (1-34) increased total body bone mass in aged female rats. J Pharmacol Exp Ther. 286:1998;341-344.
37. Stewart A., Cain R., Burr D., Jacob D., Turner C., Hock J. Six month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties A comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36 and SDZ-parathyroid hormone 893 . J Bone Miner Res. 15:2000;1517-1525.
38. Suzuki Y., Iga K., Yanai S., Matsumoto Y., Kawase M., Fukuda T., Adachi H., Higo N., Ogawa Y. Iontophoretic pulsatile transdermal delivery of human parathyroid hormone (1-34). J Pharm Pharmacol. 53:2001;1227-1234.
39. Suzuki Y., Nagase Y., Iga K., Kawase M., Oka M., Yanai S., Matsumoto Y., Nakagawa S., Fukuda T., Adachi H., Higo N., Ogawa Y. Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH(1-34). J Pharm Sci. 91:2002;350-361.
40. Tam C.S., Heersche J.N.M., Murray T.M., Parsons J.A. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action Differential effects of intermittent and continuous administration . Endocrinology. 110:1982;506-512.
41. Uzawa T., Hori M., Ejiri S., Ozawa H. Comparison of the effects of intermittent and continuous administration of human parathyroid hormone (1-34) on rat bone. Bone. 16:1995;477-484.